VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 225 filers reported holding VERACYTE INC in Q4 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $306,211 | -16.1% | 13,713 | -4.4% | 0.07% | -14.1% |
| Q2 2023 | $365,163 | +9.5% | 14,337 | -4.2% | 0.08% | +6.2% |
| Q1 2023 | $333,630 | -1.7% | 14,961 | +4.6% | 0.08% | -4.8% |
| Q4 2022 | $339,386 | +34.7% | 14,302 | -5.6% | 0.08% | +31.2% |
| Q3 2022 | $252,000 | -11.3% | 15,154 | +6.1% | 0.06% | -4.5% |
| Q2 2022 | $284,000 | -34.7% | 14,282 | -9.5% | 0.07% | -17.3% |
| Q1 2022 | $435,000 | -25.9% | 15,778 | +10.8% | 0.08% | -18.2% |
| Q4 2021 | $587,000 | -5.2% | 14,238 | +6.8% | 0.10% | -10.0% |
| Q3 2021 | $619,000 | +38.2% | 13,336 | +18.9% | 0.11% | +32.5% |
| Q2 2021 | $448,000 | +8.5% | 11,212 | +46.0% | 0.08% | -1.2% |
| Q1 2021 | $413,000 | +45.4% | 7,679 | +32.1% | 0.08% | +44.8% |
| Q4 2020 | $284,000 | +27.4% | 5,812 | -15.2% | 0.06% | +16.0% |
| Q3 2020 | $223,000 | – | 6,855 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
| ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
| EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
| Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
| Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
| ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
| Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |